Drug intelligence / Profile preview

Eye Solace drops

Development stage
Unknown
Modality
Small Molecules
Administration
Ophthalmic
01

Overview

Eye Solace drops is a generic ophthalmic solution containing a combination of five active ingredients: sodium chloride, boric acid, chlorobutanol, chlorpheniramine, and zinc sulphate. This multi-component formulation is designed to address various eye conditions, primarily by reducing swelling, providing antiseptic and astringent effects, and alleviating allergic symptoms. Sodium chloride acts as an osmotic agent to help reduce corneal edema. Boric acid and zinc sulphate offer mild antiseptic and astringent properties, contributing to eye cleansing and protection. Chlorobutanol serves as a preservative and provides mild local anesthetic and antiseptic effects. Chlorpheniramine, an antihistamine, targets allergic reactions by blocking histamine H1 receptors, thereby reducing itching and redness associated with ocular allergies. The combination aims to provide comprehensive relief for irritated and allergic eyes.

Brand names
Eye Solace drops
02

Targets

HRH1 (Histamine H1 Receptor)

Beyond the preview

Go deeper on Eye Solace drops.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eye Solace drops.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call